SynCraft web server integrates retrosynthesis and ADMET evaluation for streamlined drug design
By
Aljanabi, Qahtan Adnan, Huang, Zhijian, Song, Jinmiao, Deng, Lei
Front-window bakery material. Catches the eye, delivers the goods.
Summary
SynCraft is a newly developed web server that integrates template-based retrosynthesis with real-time ADMET (absorption, distribution, metabolism, excretion, toxicity) evaluation within a unified workflow for drug candidate design. Unlike current tools that treat synthetic feasibility and pharmacokinetic safety as separate tasks requiring manual data transfer between platforms, SynCraft streamlines the process by allowing molecular input and simultaneous evaluation of both synthetic routes and drug safety profiles. The platform addresses a key bottleneck in drug discovery by combining retrosynthetic planning with ADMET assessment in a single, integrated environment.
Key quotes
· 3 pulledThe efficient design of drug candidates requires simultaneous consideration of synthetic feasibility and pharmacokinetic safety.
Current computational tools typically address retrosynthetic planning and ADMET evaluation as separate tasks, requiring users to manually transfer data between platforms and evaluate candidate molecules in a sequential and time-consuming manner.
Here, we present SynCraft, a web server that integrates template-based retrosynthesis with real-time ADMET evaluation within a unified workflow.
You might also wanna read
ESMFold2 AI generates atlas of over 1 billion predicted protein structures, expanding known protein universe
A new open-source AI tool called ESMFold2 has generated the ESM Atlas, a database of over one billion predicted protein structures and billi
scientificamerican.com·1d ago
RNAanalyzer3: A free open-source webserver for RNA structure and motif analysis
RNAanalyzer3 is a new, free, open-source webserver that replaces the older RNAanalyzer tool. It provides detailed RNA structure analysis com
doi.org·4d ago
ChIP-Atlas 2025 update: Enhanced quality control and expanded epigenomic data-mining platform marks 10-year milestone
ChIP-Atlas, a data-mining platform for epigenomic profiling data, celebrates its 10-year anniversary with a 2025 update. The platform proces
doi.org·4d ago
Review of C2026: Grand Challenges for Predictive Modeling in Drug Discovery
This blog post reviews the C2026 preprint (Grand Challenges for Predictive Modeling in Small Molecule Drug Discovery) published on ChemXriv.
fbdd-lit.blogspot.com·4d ago
Google DeepMind CEO claims goal of "solving all disease" through AI drug discovery
This special early edition of The Verge's Optimizer newsletter, tied to Google I/O coverage, contextualizes a bold claim made by Google Deep
The Verge·11d ago
Harmonic Discovery: AI-powered platform for precision drug design launches on Product Hunt
Harmonic Discovery is a biotech platform that uses machine learning and generative chemistry to design safer, more effective medicines. The
Product Hunt·23d ago